These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 1177347)

  • 1. Chemotherapy in experimental toxoplasmosis: comparison of the efficacy of trimethoprim-sulfur and pyrimethamine-sulfur combinations.
    Seah SK
    J Trop Med Hyg; 1975 Jul; 78(7):150-3. PubMed ID: 1177347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole), pyrimethamine-sulphadiazine and spiramycin during avirulent infection with Toxoplasma gondii (Beverley strain) in mice.
    Nguyen BT; Stadtsbaeder S
    Br J Pharmacol; 1983 Aug; 79(4):923-8. PubMed ID: 6606459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparison of Ultrax, Diazil, Bactrim and Spiramycin in experimental toxoplasmosis in mice (author's transl)].
    Coradello H; Kretschmer S
    Wien Klin Wochenschr; 1978 Jan; 90(1):25-9. PubMed ID: 625985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
    Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
    Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
    Martins-Duarte ÉS; de Souza W; Vommaro RC
    Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preliminary application of PCR to curative effect assessment of chemotherapy against experimental acute infection of Toxoplasma gondii in mice].
    Xiang X; Ke OY; Zhang Z
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(1):5-7. PubMed ID: 9868016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative Chemotherapeutical studies on the effect of Bactrim and other combined preparations on the proliferative and cystforming phase of Toxoplasma gondii in NMRI mice. A contribution to experimental chemotherapy of toxoplasmosis (author's transl)].
    Werner H; Egger I
    Zentralbl Bakteriol Orig A; 1975; 231(1-3):349-64. PubMed ID: 1154912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental studies on the effect of the combination sulfamoxole/trimethoprim on the Toxoplasma infection of the mouse (author's transl)].
    Maier W; Piekarski G
    Arzneimittelforschung; 1976; 26(42):620-2. PubMed ID: 947322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental toxoplasmosis in mice. Comparative activity of clindamycin, midecamycin, josamycin, spiramycin, pyrimethamine-sulfadoxine, and trimethoprim-sulfamethoxazole].
    Garin JP; Paillard B
    Ann Pediatr (Paris); 1984 Nov; 31(10):841-5. PubMed ID: 6517460
    [No Abstract]   [Full Text] [Related]  

  • 10. Five drug regimens for treatment of acute toxoplasmosis in squirrel monkeys.
    Harper JS; London WT; Sever JL
    Am J Trop Med Hyg; 1985 Jan; 34(1):50-7. PubMed ID: 3970309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of toxoplasmosis].
    Terragna A; Canessa A
    G Ital Chemioter; 1984; 31(1-2):7-15. PubMed ID: 6381209
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of some drugs on acute toxoplasmosis in mice.
    Hamadto HH; Rashed SM; Marii NE; Sobhy MM; el-Ridi AM; el-Fakahany AF
    J Egypt Soc Parasitol; 1989 Dec; 19(2):523-6. PubMed ID: 2788673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of therapeutic effect of colchicine on murine toxoplasmosis.
    Aguirre-Cruz L; Sotelo J
    J Parasitol; 1998 Feb; 84(1):163-4. PubMed ID: 9488356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
    Romand S; Bryskier A; Moutot M; Derouin F
    J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of the combination trimethoprim-sulfamethoxazole on experimental toxoplasmosis.
    Terragna A; Rossolini A; Cellesi C; Figura N; Barberi A
    Arzneimittelforschung; 1973 Sep; 23(9):1328-31. PubMed ID: 4590193
    [No Abstract]   [Full Text] [Related]  

  • 16. Minocycline in the chemotherapy of murine toxoplasmosis.
    Tabbara KF; Sakuragi S; O'Connor GR
    Parasitology; 1982 Apr; 84(Pt 2):297-302. PubMed ID: 7070843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review.
    Iaccheri B; Fiore T; Papadaki T; Androudi S; Janjua S; Bhaila I; Stephen Foster C
    Clin Ther; 2008 Nov; 30(11):2069-74. PubMed ID: 19108794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activity of atovaquone (566C80) in murine toxoplasmosis is markedly augmented when used in combination with pyrimethamine or sulfadiazine.
    Araujo FG; Lin T; Remington JS
    J Infect Dis; 1993 Feb; 167(2):494-7. PubMed ID: 8421189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nifurtimox plus pyrimethamine for treatment of murine toxoplasmosis.
    Aguirre-Cruz L; Velasco O; Sotelo J
    J Parasitol; 1998 Oct; 84(5):1032-3. PubMed ID: 9794648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
    Romand S; Pudney M; Derouin F
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2371-8. PubMed ID: 8285620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.